Approximately a year ago, the journal Science published an article about bexarotene as a potential Alzheimer’s drug — a significant breakthrough and an important starting point for further Alzheimer’s research. Now other researchers have tested this candidate drug in various Alzheimer’s animal test models. Their results were different, as were those of two American study groups. Therefore, they have recommended that bexarotene should not be tested on patients.